MASM
PFE icon

MH & Associates Securities Management’s Pfizer PFE Stock Holding History

MH & Associates Securities Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.77M Sell
156,767
-470
-0.3% -$12.3K 3.39% 7
2026
Q1 		$4.42M Buy
+157,237
New +$4.19M 3.85% 3

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

MH & Associates Securities Management's PFE Position: Q2 2026 in Review

MH & Associates Securities Management reduced its Pfizer (PFE) stake by 0.3% in Q2 2026, selling an estimated $12.3K and leaving 156,767 shares worth $3.77M. The position accounts for 3.39% of the portfolio, ranked #7.

MH & Associates Securities Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.42M in Q1 2026. 2,017 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MH & Associates Securities Management held 156,767 shares of Pfizer worth $3.77M as of Q2 2026.
  • MH & Associates Securities Management sold 470 Pfizer shares in Q2 2026, an estimated $12.3K.
  • Pfizer made up 3.39% of MH & Associates Securities Management's portfolio in Q2 2026, its #7 holding.
  • MH & Associates Securities Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • MH & Associates Securities Management's Pfizer position peaked at $4.42M in Q1 2026.
  • 2,017 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MH & Associates Securities Management's 13F filing for Q2 2026, filed 28 Jul 2026.